14 Jul Cholesterol Explained
Total Cholesterol, LDL, HDL, Chol/HDL ratio, and fasting glucose paints a nice picture but may not tell the whole story. Factors such as Fibrinogen levels, small-particle LDL, Lp-PLA2, ApoB, and Lipoprotein (a) can reveal some underlying components that may lead to cardiovascular disease despite a proper baseline lipid panel. Fibrinogen increases lead to an increased risk of blood clots. Lp-PLA2 is an enzyme associated with blood vessel inflammation and cardiovascular disease along with lipoprotein (a) and ApoB. LDL classification adds more detail to the cardiovascular risk picture. Distinguishing between small, dense vs. large and fluffy LDL particle size plays an important role in assessing cardiovascular risk. Small and dense LDLs have an increased risk in coronary heart disease while large and fluffy LDLs tend to have a more protective effect against cardiac events.
-Nattokinase and Lumbrokinase: Natural agents used to lower fibrinogen levels
-Niacin (Vit. B3): Lowers fibrinogen, Lipoprotein (a), LDL, and CRP levels while increasing HDL levels
-Mediterranean Diet: found to increase LDL particle size